| Standard Type | PubChem Standard Value | Ki | Target Accession(s) | Ligand | Target |
|---|---|---|---|---|---|
| Ki | 0.00169 | 1.69 | P21728 | BDBM86180 | D(1A) dopamine receptor |
| Ki | 0.03394 | 33.94 | P21728 | BDBM199154 | D(1A) dopamine receptor |
| Ki | 0.02653 | 26.53 | P14416 | BDBM199154 | D(2) dopamine receptor |
| pKi_min | pKi_max | pKd_min | pKd_max | pEC50_min | pEC50_max | Type | Action | Reference (PubMed ID) |
|---|---|---|---|---|---|---|---|---|
| 7.1 | 7.1 | Antagonist | Antagonist | 1826762 | ||||
| 5.7 | 5.7 | Agonist | Partial agonist | 1826762 | ||||
| 6.2 | 6.8 | Agonist | Partial agonist | 1826762,7525564 | ||||
| 6.2 | 6.2 | Agonist | Full agonist | 1826762 | ||||
| 9.5 | 9.5 | Antagonist | Antagonist | 2144334 | ||||
| 6.9 | 6.9 | Antagonist | Antagonist | 1826762 | ||||
| 7.4 | 7.4 | Agonist | Full agonist | 1826762 | ||||
| 7.1 | 7.1 | Antagonist | Antagonist | |||||
| 5.3 | 6.2 | Agonist | Full agonist | 1826762,7525564 | ||||
| 5.6 | 5.6 | Agonist | Full agonist | 1826762 | ||||
| 7 | 7 | Antagonist | Antagonist | 15357957 | ||||
| 9.7 | 9.7 | Agonist | Biased agonist | 25660762 | ||||
| 4.3 | 5.6 | Agonist | Full agonist | 1826762,7525564 | ||||
| 9.5 | 9.5 | Antagonist | Antagonist | 2168520 | ||||
| 7 | 7 | Antagonist | Antagonist | 1826762 | ||||
| 7 | 8.4 | Antagonist | Antagonist | 1826762,7525564 | ||||
| 6.8 | 6.8 | Agonist | Agonist | 16318870 | ||||
| 6.2 | 6.2 | Agonist | Partial agonist | 1826762,12388666 | ||||
| 7.6 | 8.2 | Antagonist | Antagonist | 1826762,18308814 | ||||
| 8.3 | 8.3 | Antagonist | Antagonist | 7862709 |
| pKi_min | pKi_max | pKd_min | pKd_max | pEC50_min | pEC50_max | Type | Action | Reference (PubMed ID) |
|---|---|---|---|---|---|---|---|---|
| 5.3 | 5.3 | Antagonist | Antagonist | 1826762 | ||||
| 6 | 7.5 | Agonist | Full agonist | 1826762,12388666 | ||||
| 6.9 | 6.9 | Antagonist | Antagonist | 1826762 | ||||
| 7 | 7 | Agonist | Partial agonist | 1826762 | ||||
| 4.9 | 4.9 | Agonist | Full agonist | 1826762 | ||||
| 6.3 | 6.3 | Agonist | Full agonist | 1826762 | ||||
| 5.9 | 5.9 | Agonist | Full agonist | 1826762 | ||||
| 7.8 | 7.8 | Agonist | Full agonist | 1826762 | ||||
| 6.4 | 7.8 | Agonist | Partial agonist | 1826762,12388666 | ||||
| 7.7 | 7.7 | Agonist | Full agonist | 12388666 | ||||
| 6 | 6 | Agonist | Full agonist | 1826762 | ||||
| 9.4 | 9.4 | Antagonist | Antagonist | 1826762 | ||||
| 7.6 | 7.6 | Antagonist | Antagonist | 1826762 | ||||
| 6.6 | 6.6 | Agonist | Full agonist | 1826762 | ||||
| 9.2 | 9.2 | Antagonist | Antagonist | 8051291 | ||||
| 5.6 | 5.6 | Antagonist | Antagonist | 1826762 | ||||
| 8.1 | 8.1 | Antagonist | Antagonist | 1826762 | ||||
| 8.3 | 8.3 | Antagonist | Antagonist | 1826762 | ||||
| 6.6 | 6.6 | Agonist | Agonist | 16318870 | ||||
| 6.3 | 6.3 | Agonist | Full agonist | 1826762,12388666 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| 0.48 | Ki | = | 480 | nM | |
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| EC50 | Not Determined | ||||
| 0.13 | EC50 | = | 130 | nM | |
| Emax | = | 100 | % | ||
| 1.35 | EC50 | = | 1350 | nM | |
| EC50 | Not Determined | ||||
| 15.97 | EC50 | = | 15970 | nM | |
| Emax | = | 35.6 | % |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| IC50 | Not Determined | ||||
| Imax | Not Determined | ||||
| IC50 | Not Determined | ||||
| 21.27 | IC50 | = | 21270 | nM | |
| Imax | = | 83.5 | % | ||
| 17.37 | IC50 | = | 17370 | nM | |
| Imax | = | 78.2 | % |
| Standard Type | PubChem Standard Value | IC50 | EC50 | Target Accession(s) | Ligand | Target |
|---|---|---|---|---|---|---|
| IC50 | 0.14 | 140 | P21728 | BDBM199158 | D(1A) dopamine receptor |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| EC50 | Not Determined | ||||
| Emax | Not Determined | ||||
| EC50 | Not Determined | ||||
| 0.19 | EC50 | = | 190 | nM | |
| EC50 | Not Determined | ||||
| 13.5 | EC50 | = | 13500 | nM | |
| Emax | = | 80.7 | % |
| Standard Type | PubChem Standard Value | Ki | IC50 | Target Accession(s) | Ligand | Target |
|---|---|---|---|---|---|---|
| Ki | 0.00124 | 1.24 | 2.52 | P21728 | BDBM86180 | D(1A) dopamine receptor |
| Ki | 0.18241 | 182.41 | 323.79 | P21728 | BDBM50387556 | D(1A) dopamine receptor |
| Ki | 0.59989 | 599.89 | 758.03 | P08908 | BDBM50387556 | 5-hydroxytryptamine receptor 1A |
| Ki | 0.33438 | 334.38 | 1727.6 | P14416 | BDBM235773 | D(2) dopamine receptor |
| Ki | 0.24804 | 248.04 | 483.67 | P21728 | BDBM235777 | D(1A) dopamine receptor |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| Imax | = | 94.6 | % | ||
| Imax | Not Determined | ||||
| IC50 | Not Determined | ||||
| 18.73 | IC50 | = | 18730 | nM | |
| IC50 | Not Determined | ||||
| 1 | IC50 | = | 1000 | nM | |
| Imax | = | 58.9 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Inhibition | Not Determined | |||
| Inhibition | = | 100 | % | |
| Inhibition | = | 45.6 | % | |
| Inhibition | = | 46.6 | % | |
| Inhibition | = | 68.8 | % | |
| Inhibition | Not Determined | |||
| Inhibition | = | 20.9 | % | |
| Inhibition | = | 40.6 | % | |
| Inhibition | = | 40.4 | % | |
| Inhibition | = | 29.7 | % | |
| Inhibition | = | 49.1 | % | |
| Inhibition | = | 10.9 | % | |
| Inhibition | = | 40.5 | % | |
| Inhibition | = | 38 | % | |
| Inhibition | = | 59.1 | % |
| pKi_min | pKi_max | pKd_min | pKd_max | pIC50_min | pIC50_max | pEC50_min | pEC50_max | Concentration range (muM) | Type | Action | Reference (PubMed ID) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.7 | 7.4 | Gating inhibitor | Antagonist | 10200419,10896660,7576658 | |||||||
| 50.0-300.0 | Channel blocker | Antagonist | 7576658 | ||||||||
| 50.0-1000.0 | Channel blocker | Antagonist | 7969496 | ||||||||
| 5 | 5 | 3.0-500.0 | Channel blocker | Antagonist | 8051145,12032359,8034048 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 0.231 | Ki | = | 231 | nM | |
| 0.0034 | Ki | = | 3.4 | nM | |
| 0.05 | Ki | = | 50 | nM | |
| 0.443 | Ki | = | 443 | nM | |
| 0.022 | Ki | = | 22 | nM | |
| 0.0025 | Ki | = | 2.5 | nM | |
| 0.0173 | Ki | = | 17.3 | nM | |
| Ki | Not Determined | ||||
| 0.06 | Ki | = | 60 | nM | |
| 5 | Ki | > | 5000 | nM | |
| 0.0045 | Ki | = | 4.5 | nM | |
| 0.0063 | Ki | = | 6.3 | nM | |
| Ki | Not Determined | ||||
| 0.53 | Ki | = | 530 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 5 | Ki | > | 5000 | nM | |
| 0.011 | Ki | = | 11 | nM | |
| 0.305 | Ki | = | 305 | nM | |
| Ki | Not Determined | ||||
| 0.214 | Ki | = | 214 | nM | |
| Ki | Not Determined | ||||
| 0.147 | Ki | = | 147 | nM | |
| Ki | Not Determined | ||||
| 5 | Ki | > | 5000 | nM | |
| Ki | Not Determined | ||||
| 0.091 | Ki | = | 91 | nM | |
| 0.145 | Ki | = | 145 | nM | |
| Ki | Not Determined | ||||
| 5 | Ki | > | 5000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 5 | Ki | > | 5000 | nM | |
| 5 | Ki | > | 5000 | nM | |
| 0.149 | Ki | = | 149 | nM | |
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| 5 | Ki | > | 5000 | nM | |
| Ki | Not Determined | ||||
| 5 | Ki | > | 5000 | nM | |
| Ki | Not Determined | ||||
| Ki | Not Determined | ||||
| 0.908 | Ki | = | 908 | nM | |
| Ki | Not Determined | ||||
| Ki | Not Determined |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Inhibition | Not Determined | |||
| Inhibition | Not Determined | |||
| Inhibition | = | 99.8 | % | |
| Inhibition | = | 98.3 | % | |
| Inhibition | = | 98.8 | % | |
| Inhibition | = | 100 | % | |
| Inhibition | = | 99.1 | % | |
| Inhibition | = | 99.5 | % | |
| Inhibition | = | 88.8 | % | |
| Inhibition | = | 39.8 | % | |
| Inhibition | = | 98.7 | % | |
| Inhibition | = | 78.9 | % | |
| Inhibition | = | 99.2 | % | |
| Inhibition | = | 84.1 | % | |
| Inhibition | = | 95.2 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Inhibition | Not Determined | |||
| Inhibition | = | 100 | % | |
| Inhibition | = | 97.5 | % | |
| Inhibition | = | 88.7 | % | |
| Inhibition | = | 88.8 | % | |
| Inhibition | Not Determined | |||
| Inhibition | = | 93.4 | % | |
| Inhibition | = | 90.5 | % | |
| Inhibition | = | 71.5 | % | |
| Inhibition | = | 20.5 | % | |
| Inhibition | = | 78 | % | |
| Inhibition | = | 20.4 | % | |
| Inhibition | = | 90.9 | % | |
| Inhibition | = | 63.2 | % | |
| Inhibition | = | 79.8 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Inhibition | = | 100 | % | |
| Inhibition | Not Determined | |||
| Inhibition | = | 89.3 | % | |
| Inhibition | = | 84.4 | % | |
| Inhibition | = | 97.4 | % | |
| Inhibition | Not Determined | |||
| Inhibition | = | 14.2 | % | |
| Inhibition | = | 64.2 | % | |
| Inhibition | = | 55.4 | % | |
| Inhibition | = | 30.4 | % | |
| Inhibition | = | 82.8 | % | |
| Inhibition | = | 25.5 | % | |
| Inhibition | = | 71.1 | % | |
| Inhibition | = | 50.5 | % | |
| Inhibition | = | 60.5 | % |